Harvard Bioscience HBIO Estimates

NASDAQ HBIO
$7.90 -0.14 (-1.77%)
As of: Sep 10, 2026 · 9:46 AM EDT
Analyst Estimates

Harvard Bioscience Inc Revenue Estimates

Periods 18
Next Period Q3 26
Consensus 20.88 M

Analysts expect Harvard Bioscience Inc to report revenue of 20.88 M for Q3 26, against a range of 19.10 M to 22.67 M. The most recent reported quarter, Q2 26, came in at 22.73 M, a 9.7% beat against the 20.73 M consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) 21.97 M24.56 M21.77 M20.45 M20.59 M23.73 M20.75 M22.73 M--------
High Estimate 24.37 M25.19 M19.20 M21.62 M20.56 M23.33 M23.58 M22.04 M22.67 M26.46 M24.46 M24.13 M23.47 M25.90 M21.61 M23.99 M
Low Estimate 21.56 M21.95 M16.83 M18.15 M16.87 M20.63 M20.33 M19.41 M19.10 M24.80 M22.18 M22.17 M21.10 M22.07 M20.11 M22.38 M
Consensus Estimate 22.96 M23.57 M18.02 M19.89 M18.72 M21.98 M21.95 M20.73 M20.88 M25.63 M23.32 M23.15 M22.29 M23.99 M20.86 M23.19 M
Analyst Estimates

Harvard Bioscience Inc Earnings Per Share (EPS) Estimates

Periods 18
Next Period Q3 26
Consensus -0.16

Analysts expect Harvard Bioscience Inc to report earnings per share of -0.16 for Q3 26, against a range of -0.17 to -0.15. The most recent reported quarter, Q2 26, came in at -0.14, a 30.0% beat against the -0.20 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28
Reported (Actual) -0.200.60-0.10-0.100.000.00-0.33-0.14--------
High Estimate 0.170.54-0.38-0.220.050.37-0.59-0.18-0.150.23-0.010.150.070.410.010.19
Low Estimate 0.150.48-0.46-0.260.050.35-0.69-0.22-0.170.21-0.010.130.070.350.010.17
Consensus Estimate 0.160.51-0.42-0.240.050.36-0.64-0.20-0.160.22-0.010.140.070.380.010.18